HAOHAI BIOTEC: (1) UTILISATION OF PART OF THE OVER SUBSCRIPTION PROCEEDS FROM A SHARE OFFERING FOR PERMANENT REPLENISHMENT OF WORKING CAPITAL; (2) PURCHASE LIABILITY INSURANCE FOR DIRECTORS, SUPERVISORS AND SENIOR MANAGEMENT; AND (3) PROPOSED GENERAL MAND

HKEX · Jan 20, 2020 16:30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

昊海生物科技：( 1 ) 使用部分A 股發行超募資金永久補充流動資金；( 2 ) 爲董事、監事及高級管理人員投購責任險；及( 3 ) 建議購回H 股的一般性授權

HAOHAI BIOTEC: (1) UTILISATION OF PART OF THE OVER SUBSCRIPTION PROCEEDS FROM A SHARE OFFERING FOR PERMANENT REPLENISHMENT OF WORKING CAPITAL; (2) PURCHASE LIABILITY INSURANCE FOR DIRECTORS, SUPERVISORS AND SENIOR MANAGEMENT; AND (3) PROPOSED GENERAL MAND

Risk Disclaimer

Statement